Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
bevacizumab (avastin) (1 trial)
ex vivo expanded autologous human corneal epithelial cells containing stem cells (1 trial)
moxifloxacin (avelox) (1 trial)
vancomycin (Vancocin) (1 trial)
Trials (3 total)
Trial APIs (4 total)